---
title: "Tonghua Dongbao Pharmaceutical Co.,Ltd. (600867.SH) — Company Overview"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/600867.SH/overview.md"
symbol: "600867.SH"
name: "Tonghua Dongbao Pharmaceutical Co.,Ltd."
parent: "https://longbridge.com/en/quote/600867.SH.md"
datetime: "2026-04-04T16:02:15.688Z"
locales:
  - [en](https://longbridge.com/en/quote/600867.SH/overview.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/600867.SH/overview.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/600867.SH/overview.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/600867.SH/overview.md) | [繁體中文](https://longbridge.com/zh-HK/quote/600867.SH/overview.md)


# Tonghua Dongbao Pharmaceutical Co.,Ltd. (600867.SH) — Company Overview

## Basic Information

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Exchange | CN Market |
| Address | Dongbao New Village, Tonghua County, Jilin Province |
| Website | [www.thdb.com](https://www.thdb.com) |

## Company Profile

Tonghua Dongbao Pharmaceutical Co., Ltd. researches, develops, produces, and markets pharmaceuticals in China. It offers human insulin injections; insulin glargine injections; insulin aspart injections; liraglutide injections; and proprietary Chinese medicine. The company also provides insulin pen and pen needles; and chronic disease management platform, a diabetes management platform for drug treatment, blood glucose monitoring, and patient education.

## Key Executives

| Name | Title |
|------|-------|
| 李佳鸿 | 董事长 & 总经理 & 代理董事会秘书 |
| 范朴 | 副总裁 |
| 张国栋 | 副总经理 |
| 张文海 | 副总经理 |
| 关东亮 | 副总裁 |
| 迟军玉 | 总会计师 |
| 谷丽萍 | 证券事务代表 |

## Business Breakdown

| Segment | Revenue | Ratio |
|---------|---------|-------|
| Pharmaceutical Industry | 1973675460 | 99.86% |
| Real Estate Industry | 2690190 | 0.14% |

```vega-lite
{
  "$schema": "https://vega.github.io/schema/vega-lite/v5.json",
  "title": "Tonghua Dongbao Pharmaceutical Co.,Ltd. Business Breakdown",
  "data": {
    "values": [
      {
        "segment": "Pharmaceutical Industry",
        "ratio": 99.86
      },
      {
        "segment": "Real Estate Industry",
        "ratio": 0.14
      }
    ]
  },
  "mark": "arc",
  "encoding": {
    "theta": {
      "field": "ratio",
      "type": "quantitative"
    },
    "color": {
      "field": "segment",
      "type": "nominal"
    }
  }
}
```

## Geographic Segments

| Region | Revenue | Ratio |
|--------|---------|-------|
| China | 1873352264 | 94.79% |
| Foreign | 103013386 | 5.21% |


---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**